<SEC-DOCUMENT>0001477932-25-004185.txt : 20250527
<SEC-HEADER>0001477932-25-004185.hdr.sgml : 20250527
<ACCEPTANCE-DATETIME>20250527120612
ACCESSION NUMBER:		0001477932-25-004185
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250527
DATE AS OF CHANGE:		20250527

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cosmos Health Inc.
		CENTRAL INDEX KEY:			0001474167
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				270611758
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-86294
		FILM NUMBER:		25985914

	BUSINESS ADDRESS:	
		STREET 1:		5 AGIOU GEORGIOU, PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			55438
		BUSINESS PHONE:		312-536-3102

	MAIL ADDRESS:	
		STREET 1:		5 AGIOU GEORGIOU, PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			55438

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cosmos Holdings Inc.
		DATE OF NAME CHANGE:	20140106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIME ESTATES & DEVELOPMENTS INC
		DATE OF NAME CHANGE:	20091008

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Siokas Grigorios
		CENTRAL INDEX KEY:			0001660125
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		5 AG. GEORGIOU STR., PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			TK57001
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:ns0="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13D/A</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001660125</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>5</amendmentNo>
<securitiesClassTitle>Common Stock, Par Value $0.001 per share</securitiesClassTitle>
<dateOfEvent>04/21/2025</dateOfEvent>
<previouslyFiledFlag>true</previouslyFiledFlag>
<issuerInfo>
<issuerCIK>0001474167</issuerCIK>
<issuerCUSIP>221413206</issuerCUSIP>
<issuerName>Cosmos Health Inc.</issuerName>
<address>
<ns0:street1>5 AG. GEORGIOU STR., PILEA</ns0:street1>
<ns0:city>THESSALONIKI</ns0:city>
<ns0:stateOrCountry>J3</ns0:stateOrCountry>
<ns0:zipCode>TK57001</ns0:zipCode>
</address>
</issuerInfo>
<authorizedPersons>
<notificationInfo>
<personName>Elliot H. Lutzker</personName>
<personPhoneNum>646-428-3210</personPhoneNum>
<personAddress>
<ns0:street1>605 Third Avenue</ns0:street1>
<ns0:city>New York</ns0:city>
<ns0:stateOrCountry>NY</ns0:stateOrCountry>
<ns0:zipCode>10158</ns0:zipCode>
</personAddress>
</notificationInfo>
</authorizedPersons>
</coverPageHeader>
<reportingPersons>
<reportingPersonInfo>
<reportingPersonCIK>0001660125</reportingPersonCIK>
<reportingPersonName>Grigorios Siokas</reportingPersonName>
<fundType>PF</fundType>
<legalProceedings>N</legalProceedings>
<citizenshipOrOrganization>J3</citizenshipOrOrganization>
<soleVotingPower>6871267</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>6871267</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
<aggregateAmountOwned>6871267</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>22.9</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
</reportingPersonInfo>
</reportingPersons>
<items1To7>
<item1>
<securityTitle>Common Stock, Par Value $0.001 per share</securityTitle>
<issuerName>Cosmos Health Inc.</issuerName>
<issuerPrincipalAddress>
<ns0:street1>5 AG. GEORGIOU STR., PILEA</ns0:street1>
<ns0:city>THESSALONIKI</ns0:city>
<ns0:stateOrCountry>J3</ns0:stateOrCountry>
<ns0:zipCode>TK57001</ns0:zipCode>
</issuerPrincipalAddress>
</item1>
<item2>
<filingPersonName>Grigorios Siokas</filingPersonName>
<principalBusinessAddress>5AG Georgiou Str., Pilea, Thessaloniki J3TK 57001</principalBusinessAddress>
<principalJob>CEO, Cosmos Health, Inc., 5 Agiou Georgiou Str., Pilea, Thessaloniki, Greece J3TK 57001</principalJob>
<hasBeenConvicted>No civil proceedings to be disclosed</hasBeenConvicted>
<convictionDescription>No criminal proceedings to be disclosed</convictionDescription>
<citizenship>Greece</citizenship>
</item2>
<item3>
<fundsSource>Personal funds, none of which have been borrowed.</fundsSource>
</item3>
<item4>
<transactionPurpose>There are no plans or proposals which the reporting person has which may result in any of the matters listed.</transactionPurpose>
</item4>
<item5>
<percentageOfClassSecurities>6,871,267 (22.9%) shares based on 29,328,240 shares issued and outstanding on May 23, 2025.</percentageOfClassSecurities>
<numberOfShares>Sole voting power and disposition power - 6,871,267 shares; includes 6,158,884 issued shares; 212,383 shares issuable upon exercise of Exchange Warrants issued on October 20, 2022, pursuant to a Warrant Exchange Agreement dated as of October 3, 2022; and 500,000 shares issuable upon exercise of Series B Common Warrants exercisable at $3.00 per share sold pursuant to Registration Statement No. 333-267917.</numberOfShares>
<transactionDesc>On March 3, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 132,572 shares of common stock at an Exchange Rate of $0.4903 per share, or an aggregate of approximately $65,000, the fair market value of the Common Shares, in exchange for $65,000 the Company owed Mr. Siokas. On March 4, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 85,714 shares of common stock at an Exchange Rate of $0.525 per share, or an aggregate of approximately $45,000, the fair market value of the Common Shares, in exchange for $45,000 the Company owed Mr. Siokas. On April 21, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 654,912 shares of common stock at an Exchange Rate of $0.3176 per share, or an aggregate of approximately $208,000, the fair market value of the Common Shares, in exchange for $63,000 the Company owed Mr. Siokas.&#13; &#13; On April 22, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 208,000 shares of common stock at an Exchange Rate of $0.36 per share, or an aggregate of approximately $63,000, the fair market value of the Common Shares, in exchange for $63,000 the Company owed Mr. Siokas.  On April 23, 2025, Mr. Siokas entered into a Debt Exchange Agreement to which he acquired 205,000 common shares at an Exchange Rate of $0.40 per share, or an aggregate of approximately $82,000 the fair market value of the Common Shares, in exchange for $82,000 the Company owed Mr. Siokas. On April 24, 2025, Mr. Siokas entered into a Debt Exchange Agreement to which he acquired 177,2324 common shares at an Exchange Rate of $0.4006 per share, or an aggregate of approximately $71,000 the fair market value of the Company Shares, in exchange for $71,000 the Company owed Mr. Siokas.  On April 24, 2025, Mr. Siokas entered into a Debt Exchange Agreement to which he acquired 254,618 common shares at an Exchange Rate of $0.4006 per share, or an aggregate of approximately $102,000 the fair market value of the Company Shares, in exchange for $102,000 the Company owed Mr. Siokas. On May 19, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 79,254 common shares at an Exchange Rate of $0.429 per share, or in aggregate of approximately $34,000, the fair market rate of the Company Shares, in exchange for $34,000 the Company owed Mr. Siokas.  On May 20, 2025, Mr. Siokas entered into a Debt Exchange Agreement to which he acquired 147,563 common shares at an Exchange Rate of $0.447 per share, or an aggregate of approximately $65,962 the fair market value of the Company Shares, in exchange for $65,962 the Company owed Mr. Siokas.  On May 21, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 174,172 common shares at an Exchange Rate of $0.4708 per share, or an aggregate of approximately $82,000 the fair market value of the Company Shares, in exchange for $82,000 the Company owed Mr. Siokas. On May 22, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 141,825 common shares at an Exchange Rate of $0.4428 per share, or an aggregate of approximately $62,800 the fair market value of the Company Shares, in exchange for $62,800 the Company owed Mr. Siokas. On May 23, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 34,004 common shares at an Exchange Rate of $0.4475 per share, or an aggregate of approximately $15,217 the fair market value of the Company Shares, in exchange for $15,217 the Company owed Mr. Siokas.</transactionDesc>
<listOfShareholders>No person has the right to receive, or the power to direct the receipt of dividends from, or proceeds from, the sale of such securities.</listOfShareholders>
<date5PercentOwnership>Not applicable.</date5PercentOwnership>
</item5>
<item6>
<contractDescription>None</contractDescription>
</item6>
<item7>
<filedExhibits>None</filedExhibits>
</item7>
</items1To7>
<signatureInfo>
<signaturePerson>
<signatureReportingPerson>Grigorios Siokas</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Grigorios Siokas</signature>
<title>Chief Executive Officer</title>
<date>05/27/2025</date>
</signatureDetails>
</signaturePerson>
</signatureInfo>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
